Boaz Lahav

404 total citations
9 papers, 206 citations indexed

About

Boaz Lahav is a scholar working on Pathology and Forensic Medicine, Neurology and Immunology. According to data from OpenAlex, Boaz Lahav has authored 9 papers receiving a total of 206 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 5 papers in Neurology and 4 papers in Immunology. Recurrent topics in Boaz Lahav's work include Multiple Sclerosis Research Studies (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Epilepsy research and treatment (2 papers). Boaz Lahav is often cited by papers focused on Multiple Sclerosis Research Studies (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Epilepsy research and treatment (2 papers). Boaz Lahav collaborates with scholars based in Canada, France and Germany. Boaz Lahav's co-authors include Pierre Duquette, Alexandre Prat, Catherine Larochelle, Marc Girard, Josée Poirier, Stéphanie Zandee, Sandra Larouche, Robert Moumdjian, Alain Bouthillier and Xavier Ayrignac and has published in prestigious journals such as The Journal of Immunology, Science Translational Medicine and Epilepsia.

In The Last Decade

Boaz Lahav

9 papers receiving 206 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boaz Lahav Canada 7 69 64 46 44 34 9 206
Vivien Li Australia 9 31 0.4× 102 1.6× 30 0.7× 21 0.5× 27 0.8× 23 194
Mitja Mitrovič United States 8 151 2.2× 75 1.2× 80 1.7× 19 0.4× 14 0.4× 11 309
Stanislas Demuth France 7 67 1.0× 96 1.5× 56 1.2× 21 0.5× 9 0.3× 20 235
Nada Abdelmagid Sweden 8 90 1.3× 74 1.2× 62 1.3× 14 0.3× 8 0.2× 9 207
Bykova Ov Russia 6 29 0.4× 171 2.7× 43 0.9× 13 0.3× 13 0.4× 29 242
Fiona Tea Australia 8 59 0.9× 80 1.3× 58 1.3× 42 1.0× 7 0.2× 12 242
Su Li Poh Singapore 7 75 1.1× 8 0.1× 56 1.2× 40 0.9× 30 0.9× 8 225
Sara Lewis United States 7 34 0.5× 18 0.3× 79 1.7× 35 0.8× 11 0.3× 13 227
Carlotta Chiavazza Italy 5 38 0.6× 84 1.3× 15 0.3× 21 0.5× 9 0.3× 5 180
Andrea Vaclavkova Switzerland 5 95 1.4× 160 2.5× 181 3.9× 17 0.4× 14 0.4× 11 329

Countries citing papers authored by Boaz Lahav

Since Specialization
Citations

This map shows the geographic impact of Boaz Lahav's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boaz Lahav with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boaz Lahav more than expected).

Fields of papers citing papers by Boaz Lahav

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boaz Lahav. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boaz Lahav. The network helps show where Boaz Lahav may publish in the future.

Co-authorship network of co-authors of Boaz Lahav

This figure shows the co-authorship network connecting the top 25 collaborators of Boaz Lahav. A scholar is included among the top collaborators of Boaz Lahav based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boaz Lahav. Boaz Lahav is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Fournier, Antoine, Stéphanie Zandee, Marc Charabati, et al.. (2022). CLMP Promotes Leukocyte Migration Across Brain Barriers in Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 9(6). 9 indexed citations
2.
Laurent, Cyril, Olivier Tastet, Odile Devergne, et al.. (2021). The IL‐27/IL‐27R axis is altered in CD4+ and CD8+ T lymphocytes from multiple sclerosis patients. Clinical & Translational Immunology. 10(3). e1262–e1262. 10 indexed citations
3.
Rébillard, Rose‐Marie, Victoria Mamane, Audrey Daigneault, et al.. (2020). Increased frequency of proinflammatory CD4 T cells and pathological levels of serum neurofilament light chain in adult drug‐resistant epilepsy. Epilepsia. 62(1). 176–189. 41 indexed citations
4.
Broux, Bieke, Stéphanie Zandee, Elizabeth Gowing, et al.. (2020). Interleukin-26, preferentially produced by T H 17 lymphocytes, regulates CNS barrier function. Neurology Neuroimmunology & Neuroinflammation. 7(6). 24 indexed citations
5.
Ayrignac, Xavier, Laurent Létourneau‐Guillon, Clarisse Carra‐Dallière, et al.. (2020). From Baló’s concentric sclerosis to multiple sclerosis: a series of 6 patients. Multiple Sclerosis and Related Disorders. 42. 102078–102078. 6 indexed citations
6.
Ayrignac, Xavier, Catherine Larochelle, Mark R. Keezer, et al.. (2020). Frailty in ageing persons with multiple sclerosis. Multiple Sclerosis Journal. 27(4). 613–620. 31 indexed citations
7.
Michel, Laure, Camille Grasmuck, Marc Charabati, et al.. (2019). Activated leukocyte cell adhesion molecule regulates B lymphocyte migration across central nervous system barriers. Science Translational Medicine. 11(518). 47 indexed citations
8.
Dhaeze, Tessa, Laurence Tremblay, Catherine Lachance, et al.. (2019). CD70 defines a subset of proinflammatory and CNS-pathogenic TH1/TH17 lymphocytes and is overexpressed in multiple sclerosis. Cellular and Molecular Immunology. 16(7). 652–665. 36 indexed citations
9.
Daigneault, Audrey, Boaz Lahav, Patrick Cossette, et al.. (2019). The role of Th17 lymphocytes in drug-resistant epilepsy. The Journal of Immunology. 202(1_Supplement). 181.8–181.8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026